Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Duffaud

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
British Journal of Cancer|March 28, 2003
EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancerJ Van den Brande, P Schöffski, J H M Schellens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2012
Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trialA Patrikidou, S Chabaud, I Ray-Coquard, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 2015
Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trialsF Duffaud, S Sleijfer, S Litière, et al.
British Journal of Cancer|June 19, 2009
Prognosis and predictive value of KIT exon 11 deletion in GISTsJ-B Bachet, I Hostein, A Le Cesne, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 18, 2019
Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma GroupMarie Meurer, A Floquet, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2011
Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcomeN Penel, A Italiano, I Ray-Coquard, et al.
Pathologie-Biologie|June 1, 1997
[Clinical pilot study on repeated use of heparin, vancomycin, colimycine locked flush solution for central intravenous implanted catheter in oncology]P Guillet, B La Scola, D Bagarry-Liegey, et al.
Acta Gastro-Enterologica Belgica|March 22, 2018
Patients with primary localized high-grade sarcomas of the digestive tract excluding GIST : a retrospective study from the French sarcoma groupA de Nonneville, C Toullec, J Y Blay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 13, 2010
Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-upN Penel, A Le Cesne, B N Bui, et al.
Acta Oncologica (Stockholm, Sweden)|November 15, 2016
Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysisA Kollár, R L Jones, S Stacchiotti, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
British Journal of Cancer|March 28, 2003
EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancerJ Van den Brande, P Schöffski, J H M Schellens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2012
Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trialA Patrikidou, S Chabaud, I Ray-Coquard, et al.
European Journal of Cancer (Oxford, England : 1990)|September 1, 2015
Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trialsF Duffaud, S Sleijfer, S Litière, et al.
British Journal of Cancer|June 19, 2009
Prognosis and predictive value of KIT exon 11 deletion in GISTsJ-B Bachet, I Hostein, A Le Cesne, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 18, 2019
Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma GroupMarie Meurer, A Floquet, I Ray-Coquard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 14, 2011
Metastatic angiosarcomas: doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcomeN Penel, A Italiano, I Ray-Coquard, et al.
Pathologie-Biologie|June 1, 1997
[Clinical pilot study on repeated use of heparin, vancomycin, colimycine locked flush solution for central intravenous implanted catheter in oncology]P Guillet, B La Scola, D Bagarry-Liegey, et al.
Acta Gastro-Enterologica Belgica|March 22, 2018
Patients with primary localized high-grade sarcomas of the digestive tract excluding GIST : a retrospective study from the French sarcoma groupA de Nonneville, C Toullec, J Y Blay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 13, 2010
Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-upN Penel, A Le Cesne, B N Bui, et al.
Acta Oncologica (Stockholm, Sweden)|November 15, 2016
Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysisA Kollár, R L Jones, S Stacchiotti, et al.
Pageof 8